Trofinetide Shows Promise in Rett Syndrome

Investigational drug demonstrates modest benefit for primary, secondary endpoints

Related Keywords

United States ,American ,Judy George ,Jeffrey Neul ,American Academy Of Neurology ,Vanderbilt University In Nashville ,Vanderbilt University ,American Academy ,Rett Syndrome Behavior Questionnaire ,Clinical Global Impression ,Medpage Today ,